Skip to main content
VIYASH SCIENTIFIC LIMITED logo

VIYASH SCIENTIFIC LIMITED — Investor Relations & Filings

Ticker · VIYASH ISIN · INE807F01027 LEI · 335800SXM7D3VSHF2X07 BSE.NS Manufacturing
Open in API
Filings indexed 1,420 across all filing types
Latest filing 2025-11-28 Regulatory Filings
Country IN India
Listing BSE.NS VIYASH

About VIYASH SCIENTIFIC LIMITED

https://www.viyash.com

Viyash Scientific Limited is an integrated pharmaceutical platform specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and finished dosage forms. The organization operates a network of manufacturing facilities supported by robust research and development capabilities, focusing on complex chemistry and niche therapeutic segments. Its core business activities encompass the entire pharmaceutical value chain, from process development and scale-up to commercial-scale production. The company provides integrated solutions to global partners, leveraging its technical expertise in chemical synthesis and commitment to international quality standards. By maintaining a focus on operational excellence and innovation, the company serves as a strategic partner in the global healthcare supply chain, delivering high-quality medicinal components and formulations.

Recent filings

Filing Released Lang Actions
Scheme of Arrangement
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the intimation under Regulation 30 of SEBI Listing Regulations. It discusses the approval and sanctioning of a composite scheme of amalgamation involving multiple entities, with references to the National Company Law Tribunal order and effective dates. The content is an announcement of a corporate event (amalgamation scheme becoming effective) rather than a full report or detailed financial data. The document length is short (2534 characters) and it serves as a formal notification to the exchanges about the status of the scheme. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain financial statements or detailed report content. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-11-28 English
Update on composite scheme of amalgamation
M&A Activity Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI Listing Regulations regarding the approval and effectiveness of a composite scheme of amalgamation among multiple entities. It references the sanction order by the National Company Law Tribunal and the effective date of the scheme. The document is a formal announcement to stock exchanges about a corporate restructuring event, specifically a merger or amalgamation. It does not contain financial statements, audit information, or detailed management discussion. It is not a full report but an announcement of a corporate action related to merger activity. Therefore, the most appropriate classification is M&A Activity (TAR). The document length is short and it is not a report publication announcement or regulatory filing fallback. Confidence is high due to clear references to merger scheme and regulatory approval.
2025-11-28 English
Amendments to MOA and AOA
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding a change in the company's name and amendments to the Memorandum of Association and Articles of Association. It references regulatory compliance under SEBI Listing Regulations and details board approval via circular resolution. The content focuses on corporate governance changes, specifically the alteration of company name and objects clause, and the procedural requirements for these changes. There is no financial data, earnings information, or detailed report content. The document is an announcement of board decisions and regulatory filings related to governance changes, not a full management report or annual report. Therefore, the most appropriate classification is Board/Management Information (MANG), as it announces changes in the company's board-approved corporate structure and governance documents.
2025-11-27 English
Amendment to AOA/MOA
Board/Management Information Classification · 95% confidence The document is an official communication addressed to stock exchanges under Regulation 30 of the SEBI Listing Regulations, which pertains to disclosure of material events. It announces the approval by the Board of Directors of a change in the company's name and consequential amendments to the Memorandum of Association and Articles of Association. The document references a Scheme of Amalgamation and states that these changes are subject to shareholder and regulatory approvals. There is no financial data, earnings information, or detailed report content. The document is primarily an announcement of corporate governance changes related to the company's name and objects clause, not a full report or financial filing. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management or related corporate governance changes. The document is not a report publication announcement since it contains substantive information about the changes approved by the board, not just a notice of report availability. Therefore, the appropriate classification is MANG with high confidence.
2025-11-27 English
Record date intimation for Composite scheme of amalgamation
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the intimation of a record date for shareholders in relation to a composite scheme of amalgamation (merger) involving Sequent Scientific Limited and other entities. It specifies the record date for determining shareholders eligible for allotment of merger consideration shares and provides the share exchange ratio. The document references a certified copy of an NCLT order sanctioning the scheme, indicating it is related to merger activity. The document length is short (2424 characters) and it is an announcement of a corporate action related to merger consideration shares, not the merger agreement or detailed merger filing itself. Therefore, it fits best under Capital/Financing Update (CAP) as it updates on share allotment related to a merger scheme, rather than a full merger filing (MA) or proxy solicitation (PSI).
2025-11-26 English
Record Date
Share Issue/Capital Change Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the intimation of a record date for determining shareholders eligible for allotment of merger consideration shares under a composite scheme of amalgamation. It references a certified copy of an NCLT order sanctioning the scheme and specifies the share exchange ratio. The content is an official announcement related to corporate actions involving share allotment due to a merger. It does not contain financial statements, audit information, or detailed financial results. It is not a report itself but an announcement of a corporate action related to share capital changes due to a merger. Therefore, the document fits best under the category of Share Issue/Capital Change (SHA), as it announces the record date and share exchange ratio for allotment of shares following a merger scheme.
2025-11-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.